IGC Pharma (IGC) Other Gross PP&E Adjustments (2016 - 2025)
IGC Pharma (IGC) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with $3.9 million as the latest value for Q3 2025.
- Quarterly Other Gross PP&E Adjustments fell 34.34% to $3.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Sep 2025, down 34.34% year-over-year, with the annual reading at $5.8 million for FY2025, 2.09% down from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was $3.9 million at IGC Pharma, down from $5.9 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $13.3 million in Q4 2021, with the low at $3.9 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is $9.1 million, with a median of $9.8 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments rose 13.35% in 2021, then plummeted 40.24% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at $13.3 million in 2021, then dropped by 26.98% to $9.7 million in 2022, then decreased by 24.35% to $7.4 million in 2023, then fell by 21.01% to $5.8 million in 2024, then plummeted by 33.45% to $3.9 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $3.9 million, $5.9 million, and $5.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.